5741 - 5750 of 9033 Results
Title
Year
-
OPENTitle: Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 108Issue #:Start Page: 288End Page: 297Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.09.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6386531Citation Count: 92
-
OPENTitle: Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson’s Disease via Protein Semisynthesis and MutagenesisJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 137Issue #: 15Start Page: 5041End Page: 5052Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/ja5131726Best OA location URL: http://infoscience.epfl.ch/record/208178Citation Count: 163
-
OPENTitle: Concurrent Validity of Zeno Instrumented Walkway and Video-Based Gait Features in Adults With Parkinson’s DiseaseJournal Name: IEEE Journal of Translational Engineering in Health and MedicinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 10Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jtehm.2022.3180231Best OA location URL: https://ieeexplore.ieee.org/ielx7/6221039/6563131/09787410.pdfCitation Count: 37
-
OPENTitle: Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian DisordersJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 3Start Page: 423End Page: 435Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11481-019-09835-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6669119Citation Count: 111
-
OPENTitle: The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced DyskinesiaJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 1Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22010020Best OA location URL: https://www.mdpi.com/1422-0067/22/1/20/pdf?version=1608635348Citation Count: 11
-
OPENTitle: Feasibility, Safety, and Compliance in a Randomized Controlled Trial of Physical Therapy for Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/795294Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/795294.pdfCitation Count: 33
-
OPENTitle: Genome-wide evaluation of the effect of short tandem repeat variation on local DNA methylationJournal Name: Genome ResearchPublisher: Cold Spring Harbor LaboratoryVol: 33Issue #: 2Start Page: 184End Page: 196Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1101/gr.277057.122Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10069470/pdf/184.pdfCitation Count: 30
- Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimens2019RESTRICTEDTitle: Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimensJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 12Start Page: 1929End Page: 1930Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27891Citation Count: 5
-
OPENTitle: Long-term, stable, targeted biodelivery and efficacy of GDNF from encapsulated cells in the rat and Goettingen miniature pig brainJournal Name: Current Research in Pharmacology and Drug DiscoveryPublisher: Elsevier BVVol: 1Issue #:Start Page: 19End Page: 29Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.crphar.2020.04.001Best OA location URL: https://doi.org/10.1016/j.crphar.2020.04.001Citation Count: 22
- Amantadine in the treatment of Parkinson's disease and other movement disorders2021RESTRICTEDTitle: Amantadine in the treatment of Parkinson's disease and other movement disordersJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1048End Page: 1056Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00249-0Citation Count: 197